Careers  |  Sign In  |  Register  |   Twitter

Latest in Pulmonary Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Montelukast in primary RSV ameliorates re-infections

NEW YORK (Reuters Health) – In mice, treating primary respiratory syncytial virus (RSV) with the cysteinyl leukotriene 1 receptor antagonist montelukast reduces airway hyperresponsiveness and inflammation after RSV re-infection, according to a May 4th online report in the American Journal of...

Reuters Health • The Doctor's Channel Daily Newscast

Inhaled treprostinil improves pulmonary arterial hypertension

NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report in the May 4th Journal of the American College of Cardiology. Treprostinil is a prostacyclin analog. The...

Reuters Health • The Doctor's Channel Daily Newscast

Beta-1-selective beta-blockers safer for heart failure patients with COPD

NEW YORK (Reuters Health) – The nonselective beta-blocker carvedilol and the beta-1-selective beta-blockers metoprolol succinate and bisoprolol have significantly different treatment effects in patients with chronic heart failure and chronic obstructive pulmonary disease (COPD), a new study shows. “In...